Catalysts for Kadmon Pharmaceuticals LLC
5 tracked
Jan 15, 2026
approval
REZUROCK (BELUMOSUDIL MESYLATE) — FDA approval
belumosudil mesylate
→
Dec 30, 2024
approval
REZUROCK (BELUMOSUDIL MESYLATE) — FDA approval
belumosudil mesylate
→
Apr 10, 2024
approval
REZUROCK (BELUMOSUDIL MESYLATE) — FDA approval
belumosudil mesylate
→
Nov 9, 2023
approval
REZUROCK (BELUMOSUDIL MESYLATE) — FDA approval
belumosudil mesylate
→
Jul 16, 2021
approval
REZUROCK (BELUMOSUDIL MESYLATE) — FDA approval
belumosudil mesylate
→